Literature DB >> 10442448

Coronaviruses in spinal fluid of patients with acute monosymptomatic optic neuritis.

R B Dessau1, G Lisby, J L Frederiksen.   

Abstract

UNLABELLED: Acute monosymptomatic optic neuritis (AMON) may be an initial symptom of multiple sclerosis (MS). Coronaviruses have been implicated in the etiology of MS. The objective of the present study was to look for coronaviral RNA in AMON, which could be present in the initial stages of the development of MS.
MATERIAL AND METHODS: Spinal fluids from 37 patients with AMON and 15 surgical control patients with protrusion of the intervertebral disk were assayed with a nested multiplex polymerase chain reaction with primers specific for human coronaviruses strain (HCV) 229E and OC43.
RESULTS: Four patients and 1 control were positive for HCV-229E. No evidence of HCV-OC43 was found. The frequency of positive samples was low and there was no statistical difference between AMON and controls.
CONCLUSION: This study does not provide evidence for an etiological role of human coronaviruses in acute monosymptomatic optic neuritis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10442448      PMCID: PMC7159732          DOI: 10.1111/j.1600-0404.1999.tb01043.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients.

Authors:  A Cristallo; F Gambaro; G Biamonti; P Ferrante; M Battaglia; P M Cereda
Journal:  New Microbiol       Date:  1997-04       Impact factor: 2.479

3.  Polymerase chain reaction: replication errors and reliability of gene diagnosis.

Authors:  M Krawczak; J Reiss; J Schmidtke; U Rösler
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

4.  Human coronavirus gene expression in the brains of multiple sclerosis patients.

Authors:  J N Stewart; S Mounir; P J Talbot
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

5.  Detection of coronavirus RNA and antigen in multiple sclerosis brain.

Authors:  R S Murray; B Brown; D Brian; G F Cabirac
Journal:  Ann Neurol       Date:  1992-05       Impact factor: 10.422

6.  Sequence analysis of nucleocapsid gene and leader RNA of human coronavirus OC43.

Authors:  T Kamahora; L H Soe; M M Lai
Journal:  Virus Res       Date:  1989-01       Impact factor: 3.303

7.  Sequence analysis of the nucleocapsid protein gene of human coronavirus 229E.

Authors:  S S Schreiber; T Kamahora; M M Lai
Journal:  Virology       Date:  1989-03       Impact factor: 3.616

8.  Sequence and analysis of bovine enteritic coronavirus (F15) genome. I. Sequence of the gene coding for the nucleocapsid protein; analysis of the predicted protein.

Authors:  C Crucière; J Laporte
Journal:  Ann Inst Pasteur Virol       Date:  1988 Jan-Mar
  8 in total
  11 in total

Review 1.  Molecular analysis of cerebrospinal fluid in viral diseases of the central nervous system.

Authors:  Paola Cinque; Simona Bossolasco; Ake Lundkvist
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

2.  Should patients with sudden deafness be tested for COVID19?

Authors:  Waldemar Narożny; Andrzej Skorek; Dmitry Tretiakow
Journal:  Auris Nasus Larynx       Date:  2021-02-18       Impact factor: 1.863

Review 3.  Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective.

Authors:  Francesco Fisicaro; Mario Di Napoli; Aldo Liberto; Martina Fanella; Flavio Di Stasio; Manuela Pennisi; Rita Bella; Giuseppe Lanza; Gelsomina Mansueto
Journal:  Int J Environ Res Public Health       Date:  2021-02-03       Impact factor: 3.390

4.  Topical Ocular Povidone-Iodine as an Adjunctive Preventative Practice in the Era of COVID-19.

Authors:  Terrence P O'Brien; Jesse Pelletier
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2021-03-23

Review 5.  Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection.

Authors:  Menizibeya O Welcome; Nikos E Mastorakis
Journal:  Inflammopharmacology       Date:  2021-04-06       Impact factor: 4.473

Review 6.  SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms.

Authors:  Manuela Pennisi; Giuseppe Lanza; Luca Falzone; Francesco Fisicaro; Raffaele Ferri; Rita Bella
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

Review 7.  Neuropathogenic human coronaviruses: A review.

Authors:  Osama S Abdelaziz; Zuraiha Waffa
Journal:  Rev Med Virol       Date:  2020-07-20       Impact factor: 11.043

Review 8.  Autoimmunity in visual loss.

Authors:  Axel Petzold; Sui Wong; Gordon T Plant
Journal:  Handb Clin Neurol       Date:  2016

Review 9.  Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Pediatr Infect Dis J       Date:  2020-05       Impact factor: 3.806

Review 10.  The neurological sequelae of pandemics and epidemics.

Authors:  Fernanda Valerio; Daniel P Whitehouse; David K Menon; Virginia F J Newcombe
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.